Daniel Morgensztern, MD

Daniel Morgensztern, MD

Medical Oncologist

Primary Academic Title

Professor of Medicine, Division of Oncology, Section of Medical Oncology, WashU Medicine

Clinical Expertise

Lung cancer

Research Interest

Main clinical and translational research interests are in the development of new Phase II clinical studies for patients with lung cancer.

Education

  • 1995: MD, Fundação Técnico-Educational Souza Marques, Rio de Janeiro, Brazil

Training

  • 1996 - 1998: Resident, internal medicine and hematology, State University of Rio de Janeiro, Brazil
  • 1998 - 2001: Resident, internal medicine, University of Miami-Jackson Memorial Hospital
  • 2001 - 2004: Fellow, hematology and oncology, University of Miami-Jackson Memorial Hospital

Board Certification

  • 2001: American Board of Internal Medicine, Internal Medicine
  • 2004: American Board of Internal Medicine, Medical Oncology

Selected Research Publications

Toripalimab for Extensive-Stage Small Cell Lung Cancer.
  • Cali Daylan AE, Morgensztern D, Waqar SN
  • JAMA Oncol 2025
The changing landscape of small cell lung cancer.
  • Cittolin-Santos GF, Knapp B, Ganesh B, [...] Morgensztern D
  • Cancer 2024
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.
  • Riely GJ, Wood DE, Ettinger DS, [...] Morgensztern D, [...] Hang L
  • J Natl Compr Canc Netw 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
  • Besse B, Pons-Tostivint E, Park K, [...] Morgensztern D, [...] Heymach JV
  • Nat Med 2024
NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024.
  • Stevenson J, Ettinger DS, Wood DE, [...] Morgensztern D, [...] Hang L
  • J Natl Compr Canc Netw 2024
Incidence and risk factors for bone metastases at presentation in solid tumors.
  • Knapp BJ, Cittolin-Santos GF, Flanagan ME, [...] Morgensztern D
  • Front Oncol 2024
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  • Ettinger DS, Wood DE, Stevenson J, [...] Morgensztern D, [...] Hughes M
  • J Natl Compr Canc Netw 2023
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
  • Ettinger DS, Wood DE, Aisner DL, [...] Morgensztern D, [...] Hughes M
  • J Natl Compr Canc Netw 2023
Trends in Stage I Lung Cancer.
  • Singareddy A, Flanagan ME, Samson PP, [...] Morgensztern D
  • Clin Lung Cancer 2023
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
  • Ettinger DS, Wood DE, Aisner DL, [...] Morgensztern D, [...] Hughes M
  • J Natl Compr Canc Netw 2022

Contact Information

  • Gary C. Werths Building at Siteman Cancer Center

    4500 Forest Park Avenue
    Saint Louis, MO 63108

  • South St. Louis County

    5225 Midamerica Plaza
    St. Louis, MO 63129

Phone Numbers

Request an appointment